期刊文献+

血清氧化型低密度脂蛋白水平对颈动脉粥样硬化斑块稳定性的诊断价值 被引量:3

The diagnostic value of serum oxLDL for carotid atherosclerotic plaque stability
下载PDF
导出
摘要 目的 :探讨血清氧化型低密度脂蛋白(oxLDL)水平对颈动脉粥样硬化斑块稳定性的诊断价值。方法:选取2013年10月至2014年4月在本院内科收治的住院患者中经颈动脉超声检查确诊为动脉粥样硬化斑块者130例,根据彩色多普勒超声检查结果分为动脉粥样硬化稳定斑块组、动脉粥样硬化不稳定斑块组;选取同期在本院体检中心行颈动脉超声检查的120例健康体检者作为对照组(无斑块者),同时检测受试者清晨血清总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)及oxLDL水平。结果:3组间oxLDL水平的差异有统计学意义(F=213.11,P<0.001)。经两两比较得出,不稳定斑块组高于稳定斑块组和正常组,稳定斑块组高于正常组。oxLDL所绘制ROC曲线下面积为0.808(P<0.001)。结论:血清oxLDL水平对颈动脉粥样硬化斑块稳定性的诊断具有一定的临床价值。 Objective:This study was designed to investigate the diagnostic value of serum oxidized low density lipoprotein(ox LDL) for carotid atherosclerotic plaque stability. Methods:From Oct.2013 to Apr.2014,we enrolled 130 patients with carotid atherosclerotic plaque as the study group. All these patients were further divided into the unstable atherosclerotic plaque group and the stable atherosclerotic plaque group according to the results of color Doppler ultrasonography. Meanwhile,120 people receiving physical examination in medical examination room and diagnosed with no carotid atherosclerotic plaque were recruited as the control group. The levels of serum TC,LDL-C and ox LDL were examined in all 250 patients. Results:The difference of serum ox LDL level among three groups was statistically significant(F =213.11,P〈 0.001). The level of serum ox LDL was much higher in the unstable atherosclerotic plaque group than that of the stable atherosclerotic plaque group,and was lowest in the control group. The area under ROC curve about ox LDL were 0.863(P〈 0.01). Conclusion:The level of serum ox LDL has the diagnostic value for the stability of carotid atherosclerotic plaque.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2015年第10期1397-1400,共4页 Journal of Nanjing Medical University(Natural Sciences)
基金 江苏省医学重点人才(K201110) 江苏省自然科学基金(BK2011770)
关键词 氧化型低密度脂蛋白 不稳定斑块 诊断价值 oxidized low density lipoprotein(ox LDL) unstable atherosclerotic plaque atherosclerotic plaque stability
  • 相关文献

参考文献10

  • 1Mitra S, Deshmukh A, Sachdeva R,et al. Oxidized low- density lipoprotein and atherosclerosis implications in antioxidant therapy [J]. Am J Med Sci,2011,342 (2) : 135- 142.
  • 2Lund AK, Lueero JA, Harman M, et al. The oxidized low- density lipoprotein receptor mediates vascular effects of inhaled vehicle emissions[J]. Ame J Respir Crit Care Med,2011,184(1) : 82-91.
  • 3Li X,van der Meer JJ,van der Loos CM,et al. Microvas- cular endoglin (CDI05) expression correlates with tissue markers for atherosclerotic plaque vulnerability in an ageing population with muhivessel coronary artery disease [J]. Histopathology, 2012,61(1) : 88-97.
  • 4Ito T,Terashima M, Kaneda H, et al. Acute coronary syn- drome by disruption of a computed tomography-derived vulnerable plaque [J]. International J Cardiol, 2012,156 (3) : e55-e56.
  • 5Ramnarine KV, Garrard JW, Dexter K, et al. Shear wave elastography assessment of carotid plaque stiffness:in vitro reproducibility study [J]. Ultrasound Med Biol, 2014,40(1 ): 200-209.
  • 6Thelle DS. Cardiovascular risk factors-An aetiologically oriented epidemiologist's perspective[M]. Oral infections and cardiovascular disease, Bentham Science Publishers, New York, 2011 : 26-34.
  • 7Daviglus ML,Talavera GA,Avil6s-Santa ML, et al. Preva- lence of major cardiovascular risk factors and cardiovas- cular diseases among Hispanic/Latino individuals of di- verse backgrounds in the United States [J]. JAMA, 2012,308( 17):1775-1784.
  • 8Juonala M, Magnussen CG, Berenson GS, et al. Childhood adiposity ,adult adiposity,and cardiovascular risk factors [J]. New Eng J Med,2011,365(20) : 1876-1885.
  • 9Musso G,Cassader M,Rosina F,et al. Impact of current treatments on liver disease, glucose metabolism and car- diovascular risk in non-alcoholic fatty liver disease (NAFLD) :a systematic review and meta-analysis of ran- domised trials [ J ]. Diabetologia, 2012,55 (4) : 885 -904.
  • 10Hunt KJ,Baker N,Cleary P,et al. Oxidized LDL and AGE-LDL in circulating immune complexes strongly pre- dict progression of carotid artery IMT in type 1 diabetes [J]. Atherosclerosis, 2013,231 (2) : 315-322.

同被引文献36

  • 1中华医学会心血管病学分会心力衰竭学组,中国医师协会心力衰竭专业委员会,中华心血管病杂志编辑委员会,杨杰孚,张健,韩雅玲.中国心力衰竭诊断和治疗指南2018[J].中华心力衰竭和心肌病杂志(中英文),2018,2(4):196-225. 被引量:834
  • 2李静,常改.西雅图量表测量冠心病患者生活质量的评价[J].中国公共卫生,2004,20(5):594-594. 被引量:117
  • 3无.慢性稳定性心绞痛诊断与治疗指南[J].中华心血管病杂志,2007,35(3):195-206. 被引量:2079
  • 4Emerging Risk Factors Collaboration, Sarwar N, Gao P, et al. Diabetes meIlitus,fasting blood glucose concentration, and risk of vascular disease:a collaborative meta-analysis of 102 prospective studies [J ]. Lancet, 2010,375 (9733) : 2215-2222.
  • 5Turner RC,Millns H,Neil HA,et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus:United Kingdom Prospective Diabetes Study (UKPDS:23) [J]. BMJ, 1998,316(7134):823-828.
  • 6Ji L,Hu D,Pan C,et al. Primacy of the 3B approach to control risk factors for cardiovascular disease in type 2 diabetes patients[J]. Am J Med,2013,126(10):925e11- 22.
  • 7Fruehart JC,Sacks F,Hermans MP,et al. The Residual Risk Reduction Initiative:a call to action to reduce resid- ual vascular risk in patients with dyslipidemia [J]. Am J Cardiol, 2008,102( 10 Suppl) : 1K-34K.
  • 8Walldius G,Jungner I. The apoB/apoA-I ratio:a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy--a review of the evidence[J]. J In- tern Med, 2006,259 (5) : 493-519.
  • 9Camevale Schianca GP,Pedrazzoli R,Onolfo S,et al. ApoB/apoA-I ratio is better than LDL-C in detecting car- diovascular risk [ J ]. Nutr Metab Cardiovasc Dis, 2011,21 (6) :406-411.
  • 10Cullen P. Evidence that triglycerides are an independent coronary heart disease risk factor [J].Am J Cardiol, 2000,86(9) : 943-949.

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部